## Core Concept
Zollinger-Ellison syndrome (ZES) is a rare disorder characterized by excessive gastric acid production due to high levels of gastrin, a hormone that stimulates the stomach to release acid. The condition often results from a gastrinoma, a tumor of the pancreas or duodenum that secretes gastrin. Diagnosing ZES involves demonstrating hypergastrinemia and an acid hypersecretion state.

## Why the Correct Answer is Right
The investigation of choice for diagnosing Zollinger-Ellison syndrome is **Secretin stimulation test**. This test involves administering secretin, which normally inhibits gastrin release in healthy individuals but paradoxically increases gastrin levels in patients with ZES. The test is highly sensitive and specific for diagnosing gastrinoma and, by extension, ZES. It helps differentiate ZES from other causes of hypergastrinemia, such as atrophic gastritis or gastric outlet obstruction.

## Why Each Wrong Option is Incorrect
- **Option A:** While measuring **Fasting gastrin levels** can be a part of the diagnostic workup for ZES, it is not as specific or sensitive as the secretin stimulation test. Elevated fasting gastrin levels can be seen in various conditions, including atrophic gastritis and gastric outlet obstruction.
- **Option B:** **24-hour gastric pH monitoring** can show decreased pH levels indicating acid hypersecretion but does not directly diagnose the cause of the hyperacidity, such as ZES.
- **Option C:** **Endoscopy and biopsy** are useful for evaluating the gastrointestinal tract for complications of ZES, such as peptic ulcers, but do not directly diagnose ZES.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that patients with Zollinger-Ellison syndrome often present with severe peptic ulcer disease that is recurrent and atypical (e.g., ulcers in the second part of the duodenum or jejunum). The secretin stimulation test is particularly valuable in such cases to confirm the diagnosis.

## Correct Answer Line
**Correct Answer: D. Secretin stimulation test**